Clinical value of soluble suppression of tumourigenicity 2 (sST2) in addition to NTproBNP measurements in a general cardiac outpatient population

Authors

Camille Ammann, SWITZERLAND
Christophe Wyss, The HeartClinic Hirslanden Zurich, CH
Oliver Gämperli, The HeartClinic Hirslanden Zurich, CH
Peter Martin Wenaweser, The HeartClinic Hirslanden Zurich, CH
Roberto Corti, The HeartClinic Hirslanden Zurich, CH
Georg Noll, The HeartClinic Hirslanden Zurich, CH
Patric Biaggi, The HeartClinic Hirslanden Zurich, CH

DOI

10.4414/cvm.2021.02141

Content

PDF

Metadata

JATS XML

Icon of Creative Commons Attribution 4.0 International license Licensed under a Creative Commons Attribution 4.0 International license.

Article

Title: Clinical value of soluble suppression of tumourigenicity 2 (sST2) in addition to NTproBNP measurements in a general cardiac outpatient population
Authors: Ammann, Camille; Wyss, Christophe; Gämperli, Oliver; Wenaweser, Peter Martin; Corti, Roberto; Noll, Georg; Biaggi, Patric
DOI: 10.4414/cvm.2021.02141
Published online: 2022-11-23

Toggle